Sofinnova Investments’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-4,386,177
| Closed | -$7.72M | – | 75 |
|
2024
Q3 | $7.72M | Buy |
4,386,177
+234,601
| +6% | +$413K | 0.61% | 33 |
|
2024
Q2 | $4.86M | Buy |
4,151,576
+2,750,523
| +196% | +$3.22M | 0.25% | 50 |
|
2024
Q1 | $12.7M | Sell |
1,401,053
-371,646
| -21% | -$3.36M | 0.71% | 33 |
|
2023
Q4 | $19.3M | Buy |
1,772,699
+787,093
| +80% | +$8.56M | 1.08% | 22 |
|
2023
Q3 | $7.93M | Buy |
985,606
+22,987
| +2% | +$185K | 0.5% | 34 |
|
2023
Q2 | $10.5M | Sell |
962,619
-237,770
| -20% | -$2.58M | 0.68% | 31 |
|
2023
Q1 | $8.28M | Buy |
+1,200,389
| New | +$8.28M | 0.53% | 33 |
|
2022
Q1 | – | Sell |
-171,338
| Closed | -$2.04M | – | 76 |
|
2021
Q4 | $2.04M | Buy |
171,338
+4,627
| +3% | +$55K | 0.12% | 54 |
|
2021
Q3 | $1.9M | Sell |
166,711
-179,449
| -52% | -$2.04M | 0.11% | 57 |
|
2021
Q2 | $6.21M | Sell |
346,160
-24,191
| -7% | -$434K | 0.36% | 43 |
|
2021
Q1 | $5.73M | Buy |
370,351
+96,324
| +35% | +$1.49M | 0.34% | 44 |
|
2020
Q4 | $3.34M | Buy |
+274,027
| New | +$3.34M | 0.2% | 53 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 84 |
|